MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Parkinsonism in Uzbekistan: Clinical and Demographic Insights from 2024

    Y. Nishonova, B. Mukhammedaminov, L. Kenjaeva, N. Aripova (Tashkent, Uzbekistan)

    Objective: We retrospectively analyzed the medical records of all parkinsonism patients admitted to our clinic in 2024, examining neurological, psychiatric, radiological, and demographic characteristics of…
  • 2025 International Congress

    Burden and Resilience Among Rural Caregivers of Persons with Parkinson’s Disease

    R. Smith, L. Sancho, J. Calhoun, A. Gallentine, M. Matthiesen, C. Steim, E. Stegemöller (Ames, USA)

    Objective: To identify factors that contribute to burden and resilience among caregivers of persons with Parkinson’s Disease (PD) in the Midwestern United States. Background: Family…
  • 2025 International Congress

    A Cross-sectional Gender Gap Meta-analysis in Movement Disorders Publishing Field

    D. Garg, Z. Aldaajani, M. Auffret, T. Capato, M. Picillo, C. Trenkwalder, L. Ali, M. Armstrong, M. Bruno, V. Bruno, E. Minakawa, W. Kamel, S. Fox, D. Olszewska (New Delhi, India)

    Objective: To assess whether there is a gender gap in academic publishing within the field of movement disorders. Background: The underrepresentation of women in academia…
  • 2025 International Congress

    Nutrition, Motor And Non-Motor Symptoms Impact On Life’s Quality In Parkinson’s Disease In Second-Line Therapies

    N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes, B. Tijero, M. Ruiz-Lopez, T. Fernandez-Valle, J. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: Analyze the nutritional status, motor and non-motor symptoms of patients with Parkinson´s disease (PD) with second-line therapies [levodopa carbidopa intestinal gel (LCIG) and deep…
  • 2025 International Congress

    Hypomimia in triggered smiling in patients with Parkinson’s disease

    S. Obika, C. Trompeta, R. Rodríguez-Rojas, M. Matarazzo, A. Ruiz-Yanzi,, P. Guida, T. Jiménez, D. Urso, B. Fernández-Rodríguez, J. Obeso, C. Gasca-Salas (Madrid, Spain)

    Objective: We aimed to evaluate if Parkinson’s disease (PD) patients show decreased micro expressions in spontaneous laughing according to Action Units (AU) activation. Background: Hypomimia,…
  • 2025 International Congress

    Barriers to Healthcare Utilization and Adherence to Medications among People Living with Parkinson’s Disease in Senegal

    M. Njohjam, M. Fall, F. Niakam, J. Kahwagi, A. Diop, M. N, A. Diop (Dakar, Senegal)

    Objective: To explore the barriers to healthcare utilization and adherence to medications among people living with Parkinson’s disease in Senegal, and propose context-informed strategies to…
  • 2025 International Congress

    Studying the relationship between interoceptive awareness, caregiver burden, and disease perception in Parkinson’s Disease

    F. Velasco-Delgado, A. Hernandez-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, G. Martin-Mafud (Mexico City, Mexico)

    Objective: Analyze the impact of interoceptive awareness deficits on caregiver burden in Parkinson's disease. Background: Interoceptive awareness (IA) is the ability to perceive and process…
  • 2025 International Congress

    Aquatic Interval Training in Individuals with Parkinson’s Disease: Can It Improve Gait?

    T. Christinelli, G. Leveck, L. Paladini, S. Souza, V. Israel (Curitiba, Brazil)

    Objective: To identify changes in gait speed and gait-related activities after an aquatic interval training physiotherapy program in individuals with PD. Background: Parkinson's disease (PD)…
  • 2025 International Congress

    Cerebrospinal fluid DOPA decarboxylase levels as a marker of disease severity in Parkinson’s Disease

    K. Groenewald, L. van Hillegondsberg, T. Eisenstein, J. Klein, M. Hu (Oxford, United Kingdom)

    Objective: To assess the correlation of CSF DDC levels to DaT-SPECT SBR in PD and iRBD. Background: Raised cerebrospinal fluid (CSF) proteomic biomarker, DOPA decarboxylase…
  • 2025 International Congress

    Long term real-world monitoring supports the superiority of adaptive deep brain stimulation: preliminary data on three patients with Parkinson’s disease

    L. Caffi, R. Habib, L. Borellini, E. Mailland, F. Cogiamanian, M. Arlotti, L. Rossi, S. Bonvegna, C. Palmisano, S. Marceglia, A. Priori, G. Pezzoli, M. Locatelli, IU. Isaias (Würzburg, Germany)

    Objective: Describe the preliminary results of adaptive deep brain stimulation (aDBS) treatment for Parkinson’s disease (PD) and the value of real-world monitoring in defining clinical…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley